The Trump administration made a significant announcement on Wednesday regarding a nationwide moratorium on new suppliers for certain medical equipment. This decision was fueled by the pressing need to address the rampant “fraud, waste, and abuse” within the industry that supplies essential medical equipment such as wheelchairs, artificial limbs, and more.
During a press conference with health secretary Robert F. Kennedy, Jr. and Vice President JD Vance, Centers for Medicare and Medicaid Services Administrator Mehmet Oz highlighted the extensive scale of fraud in the industry. He emphasized that it is alarmingly easier to open a medical equipment supplier than to open a bank account, underscoring the urgency of tackling healthcare fraud head-on.
While the moratorium will not impede the distribution of medical equipment, it will impact a crucial aspect of healthcare for seniors and individuals with disabilities. The affected devices and equipment range from gauze, oxygen tanks, urinary catheters, to breast prostheses for postmastectomy patients.
The decision to implement the moratorium stemmed from a comprehensive analysis of current and historic Medicare enrollment and claims data, as outlined in a Federal Register notice. Despite the affected companies representing a small fraction of the agency’s $1.7 trillion budget, the durable medical equipment, prosthetics, orthotics, and supplies industry has been plagued by recurring instances of fraud. Federal investigations have exposed instances where Medicare erroneously paid millions to suppliers over the years.
This is not the first time that CMS has resorted to moratoriums to combat fraud, as similar measures have been employed in dealing with home health agencies and ambulance suppliers in the past. The current pause is set to last for six months, with the possibility of extensions as permitted by federal law. While specific targets for the end of the pause were not disclosed by Oz, the initiative is a crucial step towards curbing fraudulent activities within the industry.
In addition to the moratorium, federal health department leaders also announced the impending launch of a CMS tipline for reporting fraud and a temporary suspension of $259.5 million in Medicaid funding to Minnesota. These measures collectively signify a concerted effort to crack down on healthcare fraud and ensure the integrity of the medical equipment supply chain.
